BioSpace News Archive

Data, to Be Presented at 3rd International Cannabinoid-Derived Pharmaceuticals Summit on September 16, 2020, Indicate Bioavailability and Variability Challenges Can Be Addressed

Reven Holdings, Inc. (“Reven”) is a privately held clinical stage biotechnology and pharmaceutical company dedicated to the discovery and development of novel treatment platforms for cancer, viral illnesses—including COVID-19—and inflammatory disorders. Reven had recently submitted a Pre-Investigational New Drug (Pre-IND) application to the U.S. Food and Drug Administration (FDA) to obtain feedback and guidance for i

Cidara Therapeutics, Inc. (Nasdaq: CDTX), today announced that it will present two oral abstracts and seven posters at IDWeek 2020, the joint annual meeting of the Infectious Diseases Society of America (IDSA), Society for Healthcare Epidemiology of America (SHEA), the HIV Medical Association (HIVMA),

aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today announced that it has entered into a Common Stock Purchase Agreement (the “Agreement”) providing for the sale of up to $20 million of common stock to Aspire Capital Fund, LLC,

Canada-based biotechnology front-runner LuminUltra announced today that it has submitted its GeneCount® COVID-19 RT-qPCR Assay Kit (COVID-19 Assay) to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) and to Health Canada for an Interim Order (IO).

Amplyx Pharmaceuticals, announced today that Ciara Kennedy, Ph.D, president and chief executive officer, has been invited to present at A Too Quiet Pandemic – Fungal Disease webinar, presented by Maxim Group LLC and M-Vest, on Thursday September 17th, 2020.

Molecular Partners AG announced the completion of initial Good Manufacturing Practice manufacturing runs of its tri-specific, antiviral DARPin® candidate for COVID-19, named MP0420.

17 abstracts1 to be shared, spanning a wide range of different cancer types, therapies and clinical study and real-world evidence designs

Evotec SE and the French-based BIOASTER Technological Research Institute announced that they have entered into a partnership to advance research for infectious diseases.

Collaboration with NTT Research Physics and Informatics Lab to Study Methods for Improving Coherent Ising Machine Performance